These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12192)

  • 1. Adaptive responses of brain cyclic AMP-generating systems to alterations in synaptic input.
    Dismukes RK; Daly JW
    J Cyclic Nucleotide Res; 1976; 2(5):321-36. PubMed ID: 12192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of cyclic AMP content in normal and malignant brain cells.
    Perkins JP; Moore MM; Kalisker A; Su YF
    Adv Cyclic Nucleotide Res; 1975; 5():641-58. PubMed ID: 165690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nature of receptors regulating the formation of cyclic AMP in brain tissue.
    Daly JW
    Life Sci; 1976 Jun; 18(12):1349-58. PubMed ID: 7721
    [No Abstract]   [Full Text] [Related]  

  • 4. The importance of brain serotonergic receptor mechanisms for the action of antidepressant drugs.
    Ogren SO; Fuxe K; Agnati L
    Pharmacopsychiatry; 1985 Mar; 18(2):209-13. PubMed ID: 3927330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory significance of the release and action of adenine derivatives in cerebral systems.
    McIlwain H
    Biochem Soc Symp; 1972; (36):69-85. PubMed ID: 4155631
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of narcotic dependence and withdrawal on striatal dopamine-sensitive adenylate cyclase and synaptosomal cyclic AMP metabolism.
    Merali Z; Tsang B; Singhal RL; Hrdina PD
    Res Commun Chem Pathol Pharmacol; 1976 May; 14(1):29-37. PubMed ID: 180579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional aspects of the norepinephrine receptor coupled adenylate cyclase system in the limbic forebrain and its modification by drugs which precipitate or alleviate depression: molecular approaches to an understanding of affective disorders.
    Sulser F
    Pharmakopsychiatr Neuropsychopharmakol; 1978 Jan; 11(1):43-52. PubMed ID: 204950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of cyclic AMP metabolism by muscarinic cholinergic receptors.
    Harden TK; Evans T; Hepler JR; Hughes AR; Martin MW; Meeker RB; Smith MM; Tanner LI
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1985; 19():207-20. PubMed ID: 2988297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of prostaglandins and histamine with enzymes of cyclic AMP metabolism from guinea pig gastric mucosa.
    Wollin A; Code CF; Dousa TP
    J Clin Invest; 1976 Jun; 57(6):1548-53. PubMed ID: 180055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interaction of opiates and opioid peptides with cerebral mediator systems].
    Bulaev VM; Raevskiĭ KS
    Usp Fiziol Nauk; 1982; 13(2):65-92. PubMed ID: 6124068
    [No Abstract]   [Full Text] [Related]  

  • 11. Receptors acting through adenylate cyclase in the CNS.
    Wollemann M
    Acta Physiol Acad Sci Hung; 1980; 55(4):299-304. PubMed ID: 6258390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic mechanisms of action of antidepressants.
    Frazer A; Conway P
    Psychiatr Clin North Am; 1984 Sep; 7(3):575-86. PubMed ID: 6091070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coupling of neurotransmitter receptors with an adenylate cyclase. A tool for studying their pharmacological properties, distribution and modulation in the central nervous system.
    Bockaert J
    J Physiol (Paris); 1978; 74(5):527-33. PubMed ID: 218000
    [No Abstract]   [Full Text] [Related]  

  • 14. The contribution of drug research to investigating the nature of endogenous depression.
    Carlsson A
    Pharmakopsychiatr Neuropsychopharmakol; 1976 Jan; 9(1):2-10. PubMed ID: 10584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antidepressant drugs and central monoaminergic receptors].
    Asakura M; Tsukamoto T
    Yakubutsu Seishin Kodo; 1985 Dec; 5(4):303-19. PubMed ID: 2870595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic aspects of neurohormonal control of cyclic 3',5'-AMP synthesis in brain.
    Krishna G; Forn J; Voigt K; Paul M; Gessa GL
    Adv Biochem Psychopharmacol; 1970; 3():155-72. PubMed ID: 4399633
    [No Abstract]   [Full Text] [Related]  

  • 17. Central molecular aspects of tricyclic antidepressant drug action.
    Korf J
    Rev Pure Appl Pharmacol Sci; 1983; 4(2):139-212. PubMed ID: 6142505
    [No Abstract]   [Full Text] [Related]  

  • 18. Sensitization of adenylate cyclase by Galpha i/o-coupled receptors.
    Watts VJ; Neve KA
    Pharmacol Ther; 2005 Jun; 106(3):405-21. PubMed ID: 15922020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine A1 receptors inhibit adenylate cyclase activity and neurotransmitter release and hyperpolarize pyramidal neurons in rat hippocampus.
    Dunwiddie TV; Fredholm BB
    J Pharmacol Exp Ther; 1989 Apr; 249(1):31-7. PubMed ID: 2565393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulators of cyclic AMP systems.
    Hess SM; Chasin M; Free CA; Harris DN
    Adv Biochem Psychopharmacol; 1975; (14):153-67. PubMed ID: 242200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.